Protein-bound paclitaxel

(PROH-teen-bownd PA-klih-TAK-sil) A drug used to treat breast cancer that has come back or spread to other parts of the body. It is also used with carboplatin to treat advanced non-small cell lung cancer in patients who are not able to have surgery or radiation therapy. It is also used with gemcitabine hydrochloride to treat pancreatic cancer that has spread to other parts of the body. It is being studied in the treatment of other types of cancer. Protein-bound paclitaxel is a form of the anticancer drug paclitaxel and may cause fewer side effects than paclitaxel. It stops cancer cells from growing and dividing, and may kill them. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called ABI-007, Abraxane, nanoparticle paclitaxel, and paclitaxel albumin-stabilized nanoparticle formulation.

Learn more about Protein-bound paclitaxel

• Dailymed label info
• Scientific articles
• Drug portal Protein-bound paclitaxel
• toxicity info on Protein-bound paclitaxel
• FDA Protein-bound paclitaxel

Latest research - Protein-bound paclitaxel

• Most recent articles
• Most cited
• Ongoing trials

External links

• Wikipedia's article on Protein-bound paclitaxel

This WikiMD article Protein-bound paclitaxel is a stub. If you are familiar with the topic Protein-bound paclitaxel, you can help us. Paid editors welcome!